The computer firm’s hybrid and remote workers — including those based out of the Hopkinton and Franklin offices — are expected to return to the office for five days a week next month, according to a ...
Savant Labs launched its automation platform for data analysts in 2023. The company, which competes with the likes of Alteryx ...
After hours: 7:59:32 pm GMT-5 Vertex Baseline Delta ...
La Juve di scena a Como per dare continuità alla vittoria sull’Empoli, ma Motta non si fida di Fabregas. Parole al miele per Vlahovic: “Molto soddisfatto di lui” Nella trade fra Warriors e Heat ...
Vertex just won approval for a drug to treat one of the most common health problems -- pain. The biotech company is offering an option for patients and doctors who don’t want to go for ...
The FDA recently approved Journavx for treating acute pain. This approval is tremendously important for Vertex Pharmaceuticals. The biotech company has also received other good news over the last ...
Vertex has been running a number of trials because if there’s one thing that we can take away from the failed drug development projects of the past, it’s that there are many kinds of pain.
Next: Access Our New, Shockingly Simple 'Alert System' RBC Capital Markets says Vertex management is optimistic about the recently approved Alyftrek. They predict that most of the 6,000 patients ...
HOUSTON, January 22, 2025--(BUSINESS WIRE)--Vertex Energy, Inc. ("Vertex" or the "Company"), a leading specialty refiner and marketer of high-quality refined products, together with its affiliates ...
US Federal officials have approved a new pain pill by Vertex Pharmaceuticals called Journavx, aimed at reducing addiction and overdose risks associated with opioids. The drug, which works by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback